Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
Patient and Program Management
Wednesday August 06, 2025 - 07:00 to 08:00
Room: 20
13.8 Dosing of Pegcetacoplan with Plasmapheresis for Treatment of Xenoantibody Mediated Rejection
Log in to add to favorites
Add Personal Notes
Karen Khalil, United States
Presentations by Karen Khalil
Wed-06 from 07:00 - 08:00 in room 20
Patient and Program Management
Dosing of Pegcetacoplan with Plasmapheresis for Treatment of Xenoantibody Mediated Rejection
Email:
info@wtc2025.org
514-874-1717
